MedPath
FDA Approval

METFORMIN HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 28, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Metformin(850 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Preferred Pharmaceuticals Inc

791119022

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Preferred Pharmaceuticals Inc

Preferred Pharmaceuticals Inc

Preferred Pharmaceuticals Inc

791119022

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

METFORMIN HYDROCHLORIDE

Product Details

NDC Product Code
68788-7901
Application Number
ANDA203769
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 28, 2023
MetforminActive
Code: 786Z46389EClass: ACTIBQuantity: 850 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
ACACIAInactive
Code: 5C5403N26OClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
DEXTROSE, UNSPECIFIED FORMInactive
Code: IY9XDZ35W2Class: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
© Copyright 2025. All Rights Reserved by MedPath